Liver International
The tables of contents are generated automatically and are based on the data records of the individual contributions available in the index of the TIB portal. The display of the Tables of Contents may therefore be incomplete.
Table of contents
- 1213
-
Issue Information| 2022
- 1218
-
Mycophenolate and SARS‐CoV‐2 vaccination: Mixing oil and waterArenas‐De Larriva, Marisol / Rodríguez‐Perálvarez, Manuel L. et al. | 2022
- 1222
-
Decentralisation of hepatitis C virus care into community settings: A key approach on the path to eliminationBrennan, Paul N. / Byrne, Christopher J. / Dillon, John F. et al. | 2022
- 1225
-
Sars‐Cov‐2 vaccination in liver transplant recipients: The ‘holy grail’ in a hostile environmentBurra, Patrizia / Russo, Francesco Paolo et al. | 2022
- 1229
-
Haemostatic alterations in patients with cirrhosis and hepatocellular carcinoma: laboratory evidence and clinical implicationsZanetto, Alberto / Campello, Elena / Pelizzaro, Filippo et al. | 2022
- 1241
-
Seroprevalence of hepatitis C virus infection in children: A systematic review and meta‐analysisAbdel‐Gawad, Muhammad / Abd‐elsalam, Sherief / Abdel‐Gawad, Ibrahim et al. | 2022
- 1250
-
Update on the management of gastric varicesLuo, Xuefeng / Hernández‐Gea, Virginia et al. | 2022
- 1259
-
The paradigm shift from NAFLD to MAFLD: A global primary care viewpointFarahat, Taghreed M. / Ungan, Mehmet / Vilaseca, Josep et al. | 2022
- 1268
-
Peer support in small towns: A decentralized mobile Hepatitis C virus clinic for people who inject drugsMidgard, Håvard / Bjørnestad, Ronny / Egeland, Maren et al. | 2022
- 1278
-
Durability of sustained virological response to glecaprevir/pibrentasvir and resistance development: A long‐term follow‐up studyPoordad, Fred / Felizarta, Franco / Yao, Betty B. et al. | 2022
- 1287
-
Safety and antibody response to inactivated COVID‐19 vaccine in patients with chronic hepatitis B virus infectionHe, Taiyu / Zhou, Yingzhi / Xu, Pan et al. | 2022
- 1297
-
Age‐adjusted mortality and predictive value of liver chemistries in a Viennese cohort of COVID‐19 patientsHartl, Lukas / Haslinger, Katharina / Angerer, Martin et al. | 2022
- 1308
-
Impact of a Mediterranean diet on hepatic and metabolic outcomes in non‐alcoholic fatty liver disease: The MEDINA randomised controlled trialGeorge, Elena S. / Reddy, Anjana / Nicoll, Amanda J. et al. | 2022
- 1323
-
Leflunomide‐induced liver injury: Differences in characteristics and outcomes in Indian and US registriesDevarbhavi, Harshad / Ghabril, Marwan / Barnhart, Huiman et al. | 2022
- 1330
-
Management of alcohol‐related liver disease: the French Association for the Study of the Liver and the French Alcohol Society clinical guidelinesLouvet, Alexandre / Trabut, Jean‐Baptiste / Moreno, Christophe et al. | 2022
- 1344
-
A novel serum metabolomic panel distinguishes IgG4‐related sclerosing cholangitis from primary sclerosing cholangitisRadford‐Smith, Daniel E. / Selvaraj, Emmanuel A. / Peters, Rory et al. | 2022
- 1355
-
Altered DNA methylation pattern characterizes the peripheral immune cells of patients with autoimmune hepatitisZachou, Kalliopi / Arvaniti, Pinelopi / Lyberopoulou, Aggeliki et al. | 2022
- 1369
-
Liver pathology and biochemistry in patients with mutations in TRIM37 gene (Mulibrey nanism)Sivunen, Johanna / Karlberg, Susann / Kivisaari, Reetta et al. | 2022
- 1379
-
Outcomes of idiopathic versus secondary nodular regenerative hyperplasia of the liver: A longitudinal study of 167 casesPenrice, Daniel D. / Thakral, Nimish / Kezer, Camille A. et al. | 2022
- 1386
-
ABO blood group does not influence Child‐Pugh A cirrhosis outcome: An observational study from CIRRAL and ANRS CO12 CIRVIR cohortsOllivier‐Hourmand, Isabelle / Repesse, Yohann / Nahon, Pierre et al. | 2022
- 1401
-
Differential fuel utilization in liver transplant recipients and its relationship with non‐alcoholic fatty liver diseaseSiddiqui, Mohammad S. / Patel, Samarth / Forsgren, Mikael et al. | 2022
- 1410
-
Long non‐coding RNA H19 as a biomarker for hepatocellular carcinomaRojas, Ángela / Gil‐Gómez, Antonio / de la Cruz‐Ojeda, Patricia et al. | 2022
- 1423
-
Prediction of microvascular invasion in hepatocellular carcinoma with expert‐inspiration and skeleton sharing deep learningXiao, Han / Guo, Yuchen / Zhou, Qian et al. | 2022
- 1432
-
LncCDCA3L inhibits cell proliferation via a novel RNA structure‐based crosstalk with CDCA3 in hepatocellular carcinomaWang, Yongfeng / Liu, Yongzhen / Zhang, Ting et al. | 2022
- 1447
-
Acute Budd‐Chiari syndrome with thrombotic thrombocytopenia after BNT162b2 mRNA vaccinationSung, Pil S. / Oh, Jung S. / Choi, Joon‐Il et al. | 2022
- 1449
-
Targeted inhibition of PPARα ameliorates CLA‐induced hypercholesterolemia via hepatic cholesterol biosynthesis reprogrammingLiu, Hao‐Yu / Hu, Ping / Li, Yanwei et al. | 2022
- 1467
-
Hepatitis C screening during SARS‐CoV‐2 testing or vaccination. Experience in an area of southern Italy in the province of SalernoTorre, Pietro / Annunziata, Monica / Sciorio, Roberta et al. | 2022
- 1470
-
Frequency of the PNPLA3 rs738409 polymorphism and other genetic loci for liver disease in a Guatemalan adult populationLazo, Mariana / Xie, Jiaqi / Alvarez, Christian S. et al. | 2022
- 1475
-
3‐Mercaptopyruvate sulfurtransferase in hepatocellular carcinoma: Is it an authentic clinical prognostic predictor?Huo, Teh‐Ia / Liao, Jia‐I / Ho, Shu‐Yein et al. | 2022
- 1476
-
Is fresh frozen plasma transfusion associated with outcomes in acute variceal bleeding?Chen, Xiaoning / Zhu, Yueyong et al. | 2022
- 1477
-
Author’s reply| 2022
- 1478
-
Authors' response to “prevalence and incidence of fatty liver for people who took part in a health checkup in 2008–2019 in Japan”Sugiyama, Aya / Kurisu, Akemi / Akita, Tomoyuki et al. | 2022
- 1479
-
Prevalence and incidence of fatty liver for people who took part in a health checkup in 2008–2019 in JapanChen, Shiian / Liaw, Yung‐Po et al. | 2022